EFEkaterina A. Filippova

Ekaterina A. Filippova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ekaterina A. Filippova has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Immunological and neuroanatomic markers of the clinical dynamics of MCI and pre-MCI

    by I.K. Malashenkova, S.A. Krynskiy, D.P. Ogurtsov, N.A. Khailov, E.A. Filippova, S.N. Moskvina, V.L. Ushakov, V.A. Orlov, A.V. Andryushchenko, N.G. Osipova, et al.

    Objective. To study the relationship of the parameters of immunity and systemic inflammation with the structural magnetic resonance imaging (MRI) parameters in patients with mild cognitive impairment (MCI) and pre-MCI undergoing neurocognitive rehabilitation to search for candidate markers of its effectiveness. Material and methods. The main group included 49 patients, aged ≥60 years, with MCI and pre-MCI with memory impairment, who underwent a course of neurorehabilitation for 5 weeks. The control group included 19 volunteers of similar age with a total MoCA score of ≥25, who did not have cognitive impairment and immuno-inflammatory disorders. The parameters of cellular and humoral immunity and markers of inflammation were studied, and structural MRI was performed. Results. The content of activated natural killer cells (NK-cells) was increased in MCI and pre-MCI (0.63±0.12% vs. 0.22±0.07% in the control group, p=2.2·10–7). The level of immunoglobulin G (IgG) <12.5 g/l in patients with MCI and pre-MCI with the Montreal Cognitive Assessment Scale (MoCA) score <22 was associated with a decrease in the volume of the right nucleus accumbens (376±35 mm3 in patients with IgG <12.5 g/l (p=0.0013) and 480±44 mm3 at IgG <12.5 g/l, 480±44 mm3 in the control group), as well as with a decrease of the thickness and volume of a number of other cortical zones. A logistic regression model including the level of immunoglobulin G, NK cells, CD8+ NK cells and right amygdala volume was constructed to predict the number of MoCA scores 6 months after the course of rehabilitation (R2=0.57; p<1·10–5; standard error of estimate: 2.93). Conclusion. As a result of this work, the perspectives of assessing the immunological parameters in combination with socio-demographic data and morphometric changes of the brain as potential prognostic markers of the dynamics of cognitive impairment in patients with MCI and pre-MCI after neurorehabilitation has been shown.


  • Polymorphisms of IL10 Immunoregulatory Gene Impact the Morphometric Changes of the Brain in Schizophrenia

    by Irina K. Malashenkova, Vadim L. Ushakov, Sergey A. Krynskiy, Daniil P. Ogurtsov, Ekaterina I. Chekulaeva, Ekaterina A. Filippova, Vyacheslav A. Orlov, Natalia V. Zakharova, Denis S. Andreyuk, Sergey A. Trushchelev, et al.


  • Open Access

    Associations of IL17A G-197A single nucleotide polymorphism with immunological parameters and structural changes of the brain in schizophrenia

    by I. K. Malashenkova, V. L. Ushakov, S. A. Krynskiy, D. P. Ogurtsov, N. A. Khailov, A. Yu. Ratushnyy, E. A. Filippova, N. V. Zakharova, G. P. Kostyuk, Н. А. Дидковский, et al.

    Schizophrenia is a chronic mental disorder that is caused by a complex palette of genetic, epigenetic and environmental factors. Some of the important components of its pathogenesis are systemic inflammation and the dysfunction of immunity, which lead to neuroinflammation, contributing to development of structural brain changes. Earlier we have shown that increase in interleukin-17A levels is associated with morphometric changes and immune dysregulation in schizophrenia. IL17A G-197A (rs2275913) genetic polymorphism is involved in determining interleukin-17A secretion. The goal of this work was to investigate the associations between rs2275913 polymorphism, immune disorders and structural neurovisualization findings in schizophrenia to provide new insights into the immunopathogenesis of this disease. 60 patients aged 18 to 42 years diagnosed with schizophrenia were enrolled. 85 healthy volunteers were included into the control group. Multiplex assay was used to determine cytokine and chemokine serum levels. Rs2275913 polymorphism was assessed by polymerase chain reaction with electrophoretic detection of amplification products. A number of relationships between rs2275913 polymorphism and the immune parameters in schizophrenia were revealed. Carriers of G allele showed significant increase in IFNY, a key cytokine of Th1-link of adaptive immunity, and IL-8, an inflammatory chemokine. Also, increased levels of CXCL16 were observed in patients carrying the G allele. CXCL16 activates secretion of other proinflammatory chemokines and is involved in activation of Th1 adaptive immunity. Associations of heterozygous GA genotype with reduced cortical thickness in a number of areas of the frontal cortex in schizophrenia were found. Changes in cortical thickness in some of these areas, including middle frontal gyrus and orbitofrontal cortex, can be relevant to the pathogenesis of schizophrenia. The results highlight the importance of immunogenetic factors in the pathogenesis of schizophrenia and indicate that the rs2275913 polymorphism requires further studies as a potential biomarker of immune dysregulation and morphometric brain changes in schizophrenia.


  • Associations of Morphometric Changes of the Brain with the Levels of IGF1, a Multifunctional Growth Factor, and with Systemic Immune Parameters Reflect the Disturbances of Neuroimmune Interactions in Patients with Schizophrenia

    by Irina K. Malashenkova, Vadim L. Ushakov, Sergey A. Krynskiy, Daniil P. Ogurtsov, Nikita A. Khailov, Ekaterina I. Chekulaeva, Ekaterina A. Filippova, Vyacheslav A. Orlov, Nikolay A. Didkovsky, Natalia V. Zakharova, et al.